EP4626417A1 — Methods and compositions for improving driving performance
Assigned to Axsome Therapeutics Inc · Expires 2025-10-08 · 1y expired
What this patent protects
Provided herein according to some embodiments is a method of improving on-the-road driving performance in a subject in need thereof, said method comprising administering to the subject a pharmaceutically effective amount of [R]-2-amino-3-phenylpropylcarbamate (APC) or a pharmaceu…
USPTO Abstract
Provided herein according to some embodiments is a method of improving on-the-road driving performance in a subject in need thereof, said method comprising administering to the subject a pharmaceutically effective amount of [R]-2-amino-3-phenylpropylcarbamate (APC) or a pharmaceutically acceptable salt thereof, for example, in a dose of between 37.5 mg and 300 mg of APC or a pharmaceutically acceptable salt thereof, thereby improving on-the-road driving performance in the subject.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.